Global Sterile Intravenous (IV) Solution Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Sterile Intravenous (IV) Solution Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Crystalloids
  • 1.4.3 Colloids
  • 1.4.4 Others
• 1.5 Market by Application
  • 1.5.1 Global Sterile Intravenous (IV) Solution Market Share by Application (2019-2025)
  • 1.5.2 Medications
  • 1.5.3 NutritionNutrition
  • 1.5.4 Blood-based Products
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Sterile Intravenous (IV) Solution Market Size
• 2.2 Sterile Intravenous (IV) Solution Growth Trends by Regions
  • 2.2.1 Sterile Intravenous (IV) Solution Market Size by Regions (2019-2025)
  • 2.2.2 Sterile Intravenous (IV) Solution Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players

• 3.1 Sterile Intravenous (IV) Solution Market Size by by Players
  • 3.1.1 Global Sterile Intravenous (IV) Solution Revenue by by Players (2014-2019)
  • 3.1.2 Global Sterile Intravenous (IV) Solution Revenue Market Share by by Players (2014-2019)
  • 3.1.3 Global Sterile Intravenous (IV) Solution Market Concentration Ratio (CR5 and HHI)
• 3.2 Sterile Intravenous (IV) Solution Key Players Head office and Area Served
• 3.3 Key Players Sterile Intravenous (IV) Solution Product/Solution/Service
• 3.4 Date of Enter into Sterile Intravenous (IV) Solution Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Sterile Intravenous (IV) Solution Market Size by Type (2014-2019)
• 4.2 Global Sterile Intravenous (IV) Solution Market Size by Application (2014-2019)

5 North America

• 5.1 North America Sterile Intravenous (IV) Solution Market Size (2014-2019)
• 5.2 Sterile Intravenous (IV) Solution Key Players in North America
• 5.3 North America Sterile Intravenous (IV) Solution Market Size by Type
• 5.4 North America Sterile Intravenous (IV) Solution Market Size by Application

6 Europe

• 6.1 Europe Sterile Intravenous (IV) Solution Market Size (2014-2019)
• 6.2 Sterile Intravenous (IV) Solution Key Players in Europe
• 6.3 Europe Sterile Intravenous (IV) Solution Market Size by Type
• 6.4 Europe Sterile Intravenous (IV) Solution Market Size by Application

7 China

• 7.1 China Sterile Intravenous (IV) Solution Market Size (2014-2019)
• 7.2 Sterile Intravenous (IV) Solution Key Players in China
• 7.3 China Sterile Intravenous (IV) Solution Market Size by Type
• 7.4 China Sterile Intravenous (IV) Solution Market Size by Application

8 Japan

• 8.1 Japan Sterile Intravenous (IV) Solution Market Size (2014-2019)
• 8.2 Sterile Intravenous (IV) Solution Key Players in Japan
• 8.3 Japan Sterile Intravenous (IV) Solution Market Size by Type
• 8.4 Japan Sterile Intravenous (IV) Solution Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Sterile Intravenous (IV) Solution Market Size (2014-2019)
• 9.2 Sterile Intravenous (IV) Solution Key Players in Southeast Asia
• 9.3 Southeast Asia Sterile Intravenous (IV) Solution Market Size by Type
• 9.4 Southeast Asia Sterile Intravenous (IV) Solution Market Size by Application

10 India

• 10.1 India Sterile Intravenous (IV) Solution Market Size (2014-2019)
• 10.2 Sterile Intravenous (IV) Solution Key Players in India
• 10.3 India Sterile Intravenous (IV) Solution Market Size by Type
• 10.4 India Sterile Intravenous (IV) Solution Market Size by Application

11 Central & South America

• 11.1 Central & South America Sterile Intravenous (IV) Solution Market Size (2014-2019)
• 11.2 Sterile Intravenous (IV) Solution Key Players in Central & South America
• 11.3 Central & South America Sterile Intravenous (IV) Solution Market Size by Type
• 11.4 Central & South America Sterile Intravenous (IV) Solution Market Size by Application

12 International Players Profiles

• 12.1 B. Braun Medical Inc.
  • 12.1.1 B. Braun Medical Inc. Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Sterile Intravenous (IV) Solution Introduction
  • 12.1.4 B. Braun Medical Inc. Revenue in Sterile Intravenous (IV) Solution Business (2014-2019))
  • 12.1.5 B. Braun Medical Inc. Recent Development
• 12.2 Technoflex
  • 12.2.1 Technoflex Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Sterile Intravenous (IV) Solution Introduction
  • 12.2.4 Technoflex Revenue in Sterile Intravenous (IV) Solution Business (2014-2019)
  • 12.2.5 Technoflex Recent Development
• 12.3 Baxter International
  • 12.3.1 Baxter International Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Sterile Intravenous (IV) Solution Introduction
  • 12.3.4 Baxter International Revenue in Sterile Intravenous (IV) Solution Business (2014-2019)
  • 12.3.5 Baxter International Recent Development
• 12.4 ICU Medical, Inc
  • 12.4.1 ICU Medical, Inc Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Sterile Intravenous (IV) Solution Introduction
  • 12.4.4 ICU Medical, Inc Revenue in Sterile Intravenous (IV) Solution Business (2014-2019)
  • 12.4.5 ICU Medical, Inc Recent Development
• 12.5 Mckesson
  • 12.5.1 Mckesson Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Sterile Intravenous (IV) Solution Introduction
  • 12.5.4 Mckesson Revenue in Sterile Intravenous (IV) Solution Business (2014-2019)
  • 12.5.5 Mckesson Recent Development
• 12.6 Amsino
  • 12.6.1 Amsino Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Sterile Intravenous (IV) Solution Introduction
  • 12.6.4 Amsino Revenue in Sterile Intravenous (IV) Solution Business (2014-2019)
  • 12.6.5 Amsino Recent Development
• 12.7 Wallcur
  • 12.7.1 Wallcur Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Sterile Intravenous (IV) Solution Introduction
  • 12.7.4 Wallcur Revenue in Sterile Intravenous (IV) Solution Business (2014-2019)
  • 12.7.5 Wallcur Recent Development
• 12.8 Hebei Guangren Pharmaceutical Technology
  • 12.8.1 Hebei Guangren Pharmaceutical Technology Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Sterile Intravenous (IV) Solution Introduction
  • 12.8.4 Hebei Guangren Pharmaceutical Technology Revenue in Sterile Intravenous (IV) Solution Business (2014-2019)
  • 12.8.5 Hebei Guangren Pharmaceutical Technology Recent Development
• 12.9 Jiangsu Hengfengqiang Biotechnology
  • 12.9.1 Jiangsu Hengfengqiang Biotechnology Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Sterile Intravenous (IV) Solution Introduction
  • 12.9.4 Jiangsu Hengfengqiang Biotechnology Revenue in Sterile Intravenous (IV) Solution Business (2014-2019)
  • 12.9.5 Jiangsu Hengfengqiang Biotechnology Recent Development
• 12.10 Hospira
  • 12.10.1 Hospira Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Sterile Intravenous (IV) Solution Introduction
  • 12.10.4 Hospira Revenue in Sterile Intravenous (IV) Solution Business (2014-2019)
  • 12.10.5 Hospira Recent Development
• 12.11 Jiangsu Hengfengqiang Biotechnology
• 12.12 Hospira
• 12.13 Xi'an Libang Alliance Enterprise Management
• 12.14 Livzon Group

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Product (2019-2025)
• 13.2 Market Size Forecast by Application (2019-2025)
• 13.3 Market Size Forecast by Regions
• 13.4 North America
• 13.5 Europe
• 13.6 China
• 13.7 Japan
• 13.8 Southeast Asia
• 13.9 India
• 13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer